OncoMed Pharmaceuticals Inc Shareholders' Equity
OncoMed Pharmaceuticals Inc had Shareholders' Equity of $48.23 million as of 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2019-03-07
- 2018-12-31: Stockholders' Equity Attributable to Parent $48.23M.
- 2018-09-30: Stockholders' Equity Attributable to Parent $51.72M.
- 2018-06-30: Stockholders' Equity Attributable to Parent $43.98M.
- 2018-03-31: Stockholders' Equity Attributable to Parent $46.33M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2018-12-31 | $48.23M 10-K · filed 2019-03-07 |
| 2018-09-30 | $51.72M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $43.98M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $46.33M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$48.60M 10-K · filed 2019-03-07 |
| 2017-09-30 | -$62.16M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$53.79M 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$40.77M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$23.03M 10-K · filed 2019-03-07 |
| 2016-09-30 | -$3.18M 10-Q · filed 2016-11-01 |
| 2016-06-30 | -$43.54M 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$19.81M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $3.55M 10-K · filed 2019-03-07 |
| 2015-09-30 | $24.89M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $46.31M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $65.32M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $76.37M 10-K · filed 2018-03-09 |
| 2014-09-30 | $89.42M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $92.30M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $105.82M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $118.12M 10-K · filed 2017-03-09 |
| 2013-09-30 | $101.05M 10-Q · filed 2013-11-13 |
| 2013-06-30 | -$161.96M 10-Q · filed 2013-09-03 |
| 2012-12-31 | -$144.23M 10-K · filed 2016-03-10 |
| 2011-12-31 | -$122.93M 10-K · filed 2015-03-12 |
| 2010-12-31 | -$108.84M 10-K · filed 2014-03-18 |